Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death

Journal of Neuroscience Research

Volumn 87, Issue 2, 2009, Pages 333-341

  Hall, A A ^a   Guyer, A G ^a   Leonardo, C C ^a   Ajmo Jr , C T ^a   Collier, L A ^a   Willing, Alison E ^a   Pennypacker, K R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Ischemia; Myelin; Rat; Stem cells; Stroke

Indexed keywords

CASPASE 3; LACTATE DEHYDROGENASE; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; THERAPY EFFECT; WHITE MATTER; ANIMAL; CELL DEATH; CYTOLOGY; FETUS BLOOD; HUMAN; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALS; BRAIN ISCHEMIA; CASPASE 3; CELL DEATH; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 62849093766     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21857     Document Type: Article

References (47)

1. Ajmo CT Jr, Vernon DO, Collier L, Hall AA, Garbuzova-Davis S, Willing A, Pennypacker KR. 2008. The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 86:2227-2234.
2. Ajmo CT Jr, Vernon DO, Collier L, Pennypacker KR, Cuevas J. 2006. Sigma receptor activation reduces infarct size at 24 hr after permanent middle cerebral artery occlusion in rats. Curr Neurovasc Res 3:89-98.
3. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22:455-463.
4. Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N, Fern R. 2007. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 27:334-347.
5. Barres BA, Raff MC. 1999. Axonal control of oligodendrocyte development. J Cell Biol 147:1123-1128.
6. Barres BA, Schmid R, Sendnter M, Raff MC. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
7. Bracci-Laudiero L, Celestino D, Starace G, Antonelli A, Lambiase A, Procoli A, Rumi C, Lai M, Picardi A, Ballatore G, Bonini S, Aloe L. 2003. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J Neuroimmunol 136:130-139.
8. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR. 2002. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res 929:252-260.
9. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. 2001. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682-2688.
10. Coirault C, Guellich A, Barbry T, Samuel JL, Riou B, Lecarpentier Y. 2007. Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 292:H1009-H1017.
11. Craig A, Ling Luo N, Beardsley DJ, Wingate-Pearse N, Walker DW, Hohimer AR, Back SA. 2003. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231-240.
12. David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, Abraini JH. 2003. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 23:1168-1173.
13. Dewar D, Underhill SM, Goldberg MP. 2003. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 23:263-274.
14. Dingley J, Tooley J, Porter H, Thoresen M. 2006. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 37:501-506.
15. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. 2000. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20:9235-9241.
16. Gottschall PE, Yu X, Bing B. 1995. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 42:335-342.
17. Gresle MM, Jarrott B, Jones NM, Callaway JK. 2006. Injury to axons and oligodendrocytes following endothelin-1-induced middle cerebral artery occlusion in conscious rats. Brain Res 1110:13-22.
18. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
19. Hagberg H, Peebles D, Mallard C. 2002. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 8:30-38.
20. Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR. 2004. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 13:729-739.
21. Henning RJ, Burgos JD, Ondrovic L, Sanberg P, Balis J, Morgan MB. 2006. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 15:647-658.
22. Jelinski SE, Yager JY, Juurlink BH. 1999. Preferential injury of oligodendroblasts by a short hypoxic-ischemic insult. Brain Res 815:150-153.
23. Kaur C, Sivakumar V, Ang LS, Sundaresan A. 2006. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem 98:1200-1216.
24. Lee YB, Nagai A, Kim SU. 2002. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69:94-103.
25. Lewen A, Matz P, Chan PH. 2000. Free radical pathways in CNS injury. J Neurotrauma 17:871-890.
26. Li X, Cheng C, Fei M, Gao S, Niu S, Chen M, Liu Y, Guo Z, Wang H, Zhao J, Yu X, Shen A. 2008. Spatiotemporal expression of Dexras1 after spinal cord transection in rats. Cell Mol Neurobiol 28:371-388.
27. Love S. 1999. Oxidative stress in brain ischemia. Brain Pathol 9:119-131.
28. Lyons SA, Kettenmann H. 1998. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J Cereb Blood Flow Metab 18:521-530.
29. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, Hori M, Matsumoto M. 2000. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31:1735-1743.
30. Marcus J, Dupree JL, Popko B. 2002. Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions. J Cell Biol 156:567-577.
31. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
32. Miller AK, Alston RL, Corsellis JA. 1980. Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser. Neuropathol Appl Neurobiol 6:119-132.
33. Newcomb JD, Ajmo CT Jr. Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE. 2006. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 15:213-223.
34. Newman MB, Willing AE, Manresa JJ, Sanberg CD, Sanberg PR. 2006. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol 199:201-208.
35. Pantoni L, Garcia JH, Gutierrez JA. 1996. Cerebral white matter is highly vulnerable to ischemia. Stroke 27:1641-1646; discussion1647.
36. Ratajczak MZ, Ratajczak J, Machalinski B, Majka M, Marlicz W, Carter A, Píetrzkowski Z, Gewirtz AM. 1998. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human haemopoietic cell growth. Br J Haematol 103:969-979.
37. Reynolds R, Hardy R. 1997. Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 47:455-470.
38. Saporta S, Kim JJ, Willing AE, Fu ES, Davis CD, Sanberg PR. 2003. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematotber Stem Cell Res 12:271-278.
39. Shibata M, Hisahara S, Hara H, Yamawaki T, Fukuuchi Y, Yuan J, Okano H, Miura M. 2000. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J Clin Invest 106:643-653.
40. Sommer I, Schachner M. 1982. Cell that are O4 antigen-positive and O1 antigen-negative differentiate into O1 antigen-positive oligodendrocytes. Neurosci Lett 29:183-188.
41. Tanaka K, Fukuuchi Y, Nogawa S, Ito D, Suzuki S, Dembo T, Kosakai A. 2001. [Targets of treatment in the acute phase of cerebral infarction]. Rinsho Shinkeigaku 41:1052-10541.
42. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE. 2004. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35:2390-2395.
43. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE. 2005. Antiinflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14:595-604.
44. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR, Willing AE. 2006. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol. 199:191-200.
45. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR. 2003. Intravenous vs. intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 73:296-307.
46. Wolf PA, Kannel WB. 2007. Preventing stroke: does race/ethnicity matter? Circulation 116:2099-2100.
47. Yang Z, Watanabe M, Nishiyama A. 2005. Optimization of oligodendrocyte progenitor cell culture method for enhanced survival. J Neurosci Methods 149:50-56.